Skip to main content

Peer Review reports

From: Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs

Original Submission
5 May 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
21 May 2022 Reviewed Reviewer Report - Weinan Xue
23 Jun 2022 Reviewed Reviewer Report
6 Jul 2022 Author responded Author comments - Qing Chang
Resubmission - Version 3
6 Jul 2022 Submitted Manuscript version 3
9 Jul 2022 Author responded Author comments - Qing Chang
Resubmission - Version 4
9 Jul 2022 Submitted Manuscript version 4
12 Jul 2022 Author responded Author comments - Qing Chang
Resubmission - Version 5
12 Jul 2022 Submitted Manuscript version 5
14 Jul 2022 Reviewed Reviewer Report
22 Jul 2022 Reviewed Reviewer Report - Weinan Xue
15 Sep 2022 Author responded Author comments - Qing Chang
Resubmission - Version 6
15 Sep 2022 Submitted Manuscript version 6
17 Sep 2022 Author responded Author comments - Qing Chang
Resubmission - Version 7
17 Sep 2022 Submitted Manuscript version 7
20 Sep 2022 Reviewed Reviewer Report
28 Sep 2022 Author responded Author comments - Qing Chang
Resubmission - Version 8
28 Sep 2022 Submitted Manuscript version 8
Publishing
30 Sep 2022 Editorially accepted
18 Oct 2022 Article published 10.1186/s12859-022-04969-4

You can find further information about peer review here.

Back to article page